Atara Biotherapeutics, Inc. (ATRA) vs VAXART, INC. (VXRT)
- Atara Biotherapeutics, Inc. ATRA 9.48 +2.71%
- VAXART, INC. VXRT 0.43 0.00%
Atara Biotherapeutics, Inc. and VAXART, INC. are both Biotechnology companies. Atara Biotherapeutics, Inc. and VAXART, INC. are of similar size ($92.6M and $92.4M). Atara Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 201.1% against −96.7%. VAXART, INC. has the higher net margin (15.9% vs −269.4%) and the higher return on invested capital (134.6% vs 0.00%). Across the 15 metrics below, VAXART, INC. leads on 13 and Atara Biotherapeutics, Inc. on 2.
Valuation
Profitability
| Metric | ATRA | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.38% | 100.00% | 65.16% |
| Operating margin | (229.67%) | 16.30% | 0.00% |
| Net margin | (269.42%) | 15.88% | 0.00% |
| Free cash flow margin | (353.49%) | 13.74% | 0.00% |
| Return on equity | 46.33% | 66.97% | (56.66%) |
| Return on assets | (57.62%) | 23.44% | (49.22%) |
| Return on invested capital | 0.00% | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack